These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 6152758

  • 1. Pseudotype viruses bearing envelope antigens of Japanese isolates of human T-cell leukemia viruses type I.
    Hoshino H, Weiss RA, Clapham P, Miwa M, Miyoshi I, Yoshida M, Sugimura T.
    Princess Takamatsu Symp; 1984; 15():159-64. PubMed ID: 6152758
    [Abstract] [Full Text] [Related]

  • 2. Human T-cell leukemia virus type I: pseudotype neutralization of Japanese and American isolates with human and rabbit sera.
    Hoshino H, Clapham PR, Weiss RA, Miyoshi I, Yoshida M, Miwa M.
    Int J Cancer; 1985 Dec 15; 36(6):671-5. PubMed ID: 2415468
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antibodies to human immuno-deficiency virus and human T-cell leukemia virus type I in Japanese patients with hematologic malignancies.
    Tobinai K, Minato K, Shimoyama M, Kawatani T, Kurimura T.
    Jpn J Cancer Res; 1986 Dec 15; 77(12):1207-10. PubMed ID: 2880831
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
    Fischinger PJ, Robey WG, Koprowski H, Gallo RC, Bolognesi DP.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Production of oncogene-specific proteins and human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein in bacteria and its potential for use in human cancers and seroepidemiological surveys.
    Papas TS, Samuel KP, Kan NC, Ascione R, Wong-Staal F, Lautenberger JA.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4568s-4573s. PubMed ID: 2861893
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of anti-HTLV antibody titer, abnormal lymphocytes in HTLV carriers and HTLV genome negative adult T-cell leukemia-lymphoma.
    Shimoyama M, Seki S, Nagai M, Minato K, Kitamura T, Hoshino H, Miwa M, Tobinai K, Nagoshi H, Oosuga T.
    Princess Takamatsu Symp; 1984 Sep 15; 15():71-6. PubMed ID: 6152761
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
    Palker TJ, Scearce RM, Ho W, Copeland TD, Oroszlan S, Popovic M, Haynes BF.
    J Immunol; 1985 Jul 15; 135(1):247-54. PubMed ID: 2987346
    [Abstract] [Full Text] [Related]

  • 15. Antigenicity of human T-cell leukemia virus-associated gp52: greater response in leukemia patients compared to healthy donors exposed to the virus.
    Robert-Guroff M, Clark JW.
    Cancer Res; 1985 Jul 15; 45(7):3374-7. PubMed ID: 2988770
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HTLV-I, the prototype human retrovirus: epidemiologic features.
    Blattner WA, Saxinger CW, Gallo RC.
    Prog Clin Biol Res; 1985 Jul 15; 182():223-43. PubMed ID: 2994100
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.